Home » Topics » Regulatory

Regulatory
RSS

Advate approved for bleeding episodes in patients with hemophilia A

July 30, 2003

Positive opinion handed down in Europe for new Synagis indication

July 30, 2003

FDA approves palonosetron for CINV

July 29, 2003

CPMP issues positive opinion for Bondronat for metastatic bone disease

July 29, 2003

Diovan approved in Switzerland for ACE inhibitor-intolerant heart failure patients

July 29, 2003

Enbrel becomes the first FDA-approved biologic for ankylosing spondylitis

July 28, 2003

Zyvox approved for diabetic foot infections

July 28, 2003

Sweden is the first to approve transplant drug Certican

July 25, 2003

Manufacturing approval granted for pitavastatin

July 23, 2003

New European label for Pegasys reflects new genotype data

July 22, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.